Research Areas
Research Area Ⅱ

Preclinical Animal Modeling–Driven Next-Generation Immunotherapy for Companion Animals

1. Why Immunotherapy Is Still Inaccessible in Companion Animals

Despite the high incidence of cancer in companion animals, advanced immunotherapies remain largely unavailable. Current approaches such as CAR-T rely on ex vivo cell engineering, making them costly, complex, and impractical in routine veterinary settings.

What is needed is a fundamentally different approach:

an immunotherapy that is accessible like vaccination,
affordable for pet owners, and scalable in clinical practice.

To address this, we develop a next-generation strategy based on:

  • In vivo CAR-T using mRNA-LNP delivery (Collaboration with SNU, Prof. Byung-Soo Kim)
  • – Extracellular vesicle (EV)-mediated modulation of tumor microenvironment

This combination enables a simplified, cost-effective, and clinically applicable immunotherapy platform (Collaboration with SNU, Prof. Kyung-Rok Yu).

2. A Paradigm Shift in Animal Modeling

Developing therapies for companion animals has long relied on an inherent paradox:
the use of dogs as experimental subjects.

To overcome this limitation, we establish a next-generation preclinical platform based on:

companion animal–derived disease modeling in rodent “avatar” systems

By integrating:

  • – Canine tumor–derived PDX/CDX models that preserve tumor heterogeneity
  • – Canine immune–relevant (caninized) modeling systems to recapitulate immunotherapeutic responses.
  •  
  • Thus, we establish preclinical platforms that faithfully reflect clinical disease biology, while minimizing the direct experimental use of companion animals.

 

3. Clinically Integrated Animal Medicine

Successful translation requires more than modeling—it demands real clinical integration (Collaboration with EULJI Univ, Prof. Geon A Kim).

We therefore establish a nationwide collaborative network:

  • – Multi-center veterinary hospitals for sample acquisition and validation
  • – Standardized pipelines for ex vivo and in vivo testing
  • – Direct linkage between clinical cases and experimental models

Through this system, we position laboratory animal medicine not as a separate discipline, but as: a field that directly connects preclinical modeling and real-world clinical practice

 

그림 1. 반려동물을 위한 차세대 면역 치료제 전략 (서울대 김병수, 유경록 교수님 치료제 팀)
그림 2. 반려동물을 위한 설치류 아바타 종양 모델 구축
그림 3. 전국 30개 동물병원들과 반려동물 환자 샘플 공급 협력체 구성